A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Fluzoparib|DRUG: Apatinib
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Collaborators: Peking University Cancer Hospital & Institute